Vous avez cherché: awtoantikorpi (Maltais - Anglais)

awtoantikorpi
autoantibodies

formazzjoni awtoantikorpi
autoantibody formation

formazzjoni tal-awtoantikorpi
autoantibody formation

awtoantikorpi u disturbi awtoimmunitarji
auto-antibodies and autoimmune disorders

effikaċja f’pazjenti seropożittivi għall-awtoantikorpi (rf u jew anti-ccp)
efficacy in autoantibody (rf and or anti-ccp) seropositive patients

formazzjoni għola ta’ awtoantikorpi tista’ tidher matul il-kura bl-interferon beta.
an increased formation of auto-antibodies may occur during treatment with interferon beta.

l-iżvilupp ta’ awtoantikorpi u disturbi awtoimmuni ġie rrappurtat waqt il-kura b’alfa interferons.
the development of auto-antibodies and autoimmune disorders has been reported during treatment with alpha interferons.

epatite awtoimmuni (mingħajr il-preżenza ta’ awtoantikorpi) ġiet osservata fil-provi kliniċi.
autoimmune hepatitis (without the presence of auto-antibodies) has been observed in clinical studies.

l-iżvilupp ta’ awtoantikorpi u problemi ta’ awtoimmunità kienu irrappurtati waqt it-trattament bl- interferoni alpha.
the development of auto-antibodies and autoimmune disorders has been reported during treatment with alpha interferons.

kumplikazzjonijiet ta’ tma severa seħħew fil-pazjenti irrispettivament minn jekk dawn kellhomx mutazzjoni ġenetika identifikata, polimorfiżmu ta’ riskju għoli jew awtoantikorpi.
severe tma complications occurred in patients regardless of whether they had an identified genetic mutation, high risk polymorphism or auto-antibody.

emofilja akkwiżita hija marda bil-fsada rari fejn pazjenti b'ġeni tal-fattur viii normali jiżviluppaw awtoantikorpi inibitorji mmirati kontra l-fattur viii.
acquired haemophilia is a rare bleeding disorder in which patients with normal factor viii genes develop inhibitory autoantibodies directed against factor viii.

l- iżvilupp ta ’ awtoantikorpi u problemi ta ’ awtoimmunità kienu irrappurtati waqt it- trattament bl - ’ għ interferoni alpha.
the development of auto-antibodies and autoimmune disorders has been reported during treatment with alpha lon interferons.

kien hemm rapporti ta ’ każijiet rari ta ’ pazjenti, inkużi ukoll ta ’ pazjenti b’ fattur pożittiv rewmatojdu, li żviluppaw awtoantikorpi oħra flimkien ma ’ sindrome bħal tal- lupus jew raxx li huma kompatibbli ma ’ lupus tal- ġilda sottoakut jew discoid lupus bi preżentazzjoni klinika u bijopsija.
93 there have been rare reports of patients, including rheumatoid factor positive patients, who have developed other autoantibodies in conjunction with a lupus-like syndrome or rashes that are compatible with subacute cutaneous lupus or discoid lupus by clinical presentation and biopsy.